Skip to main content

Table 3 Parameters of visceral organ (liver, kidney) hemodynamics, acid-base status and organ function in the control (n = 12, n = 11 at 24 hours of peritonitis) and AVP (n = 12) groups

From: Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial

  

Before peritonitis

12 hours peritonitis

18 hours peritonitis

24 hours peritonitis

Portal vein flow (mL/kg/min)

Control

18 (15 to 22)

29 (21 to 31)b

29 (24 to 34)b

26 (24 to 30)b

 

AVP

18 (16 to 20)

24 (20 to 31)b

22 (16 to 27)

20 (16 to 24)

Hepatic artery flow (mL/kg/min)

Control

1.7 (0.4 to 2.1)

1.4 (0.9 to 2.9)

1.6 (1.3 to 3.5)

2.1 (1.1 to 3.6)b

 

AVP

0.6 (0.2 to 1.6)

1.6 (0.2 to 3.2)b

1.9 (0.3 to 3.3)b

3.0 (0.3 to 5.5)b

Hepatic O2 delivery

(mL/kg/min)

Control

1.0 (0.9 to 1.5)

2.9 (2.5 to 3.7)b

3.0 (2.0 to 3.5)b

2.6 (1.8 to 3.1)b

 

AVP

1.2 (1.0 to 1.5)

2.5 (1.9 to 3.0)b

2.2 (1.7 to 3.0)b

2.3 (1.4 to 2.7)b

Portal vein O2 saturation (%)

Control

58 (55 to 64)

78 (76 to 81)b

77 (71 to 79)b

72 (67 to 74)b

 

AVP

60 (55 to 63)

78 (68 to 83)b

72 (65 to 75)b

69 (63 to 71)b

Hepatic vein O2 saturation (%)

Control

AVP

25 (24 to 72)

63 (54 to 65)b

58 (52 to 65)b

53 (44 to 56)b

  

30 (20 to 55)

66 (50 to 70)b

54 (42 to 61)b

55 (50 to 58)b

Portal drained viscera O2 extraction (%)

Control

AVP

40 (37 to 46)

21 (18 to 24)b

21 (18 to 25)b

27 (24 to 34)b

  

43 (37 to 44)

22 (17 to 35)b

22 (19 to 31)b

30 (25 to 34)b

Hepatic O2 uptake

Control

0.6 (0.4 to 0.8)

0.6 (0.4 to 0.9)

0.7 (0.5 to 1.1)

0.6 (0.4 to 0.8)

(mL/kg/min)

AVP

0.6 (0.5 to 0.9)

0.8 (0.5 to 0.9)

0.7 (0.4 to 1.0)

0.5 (0.3 to 0.7)

Portal vein

Control

10 (9 to 12)

14 (12 to 15)

15 (13 to 17)

16 (13 to 18)a

lactate/pruvate ratio

AVP

11 (10 to 12)

13 (11 to 15)

14 (13 to 15)

15 (13 to 17)a

Hepatic vein

Control

9 (8 to 10)

12 (10 to 15)

13 (12 to 15)

14 (12 to 18)a

lactate/pruvate ratio

AVP

8 (7 to 12)

12 (10 to 15)

11 (10 to 16)

13 (11 to 16)a

Portal vein pH

Control

7.49 (7.46 to 7.52)

7.46 (7.42 to 7.48)

7.41 (7.38 to 7.45)b

7.37 (7.33 to 7.42)b

 

AVP

7.48 (7.43 to 7.51)

7.47 (7.44 to 7.49)b

7.44 (7.39 to 7.47)b

7.42 (7.37 to 7.43)b

Hepatic vein pH

Control

7.49 (7.47 to 7.53)

7.48 (7.43 to 7.49)

7.43 (7.40 to 7.46)b

7.39 (7.33 to 7.44)b

 

AVP

7.49 (7.44 to 7.54)

7.47 (7.44 to 7.50)

7.43 (7.39 to 7.48)b

7.44 (7.40 to 7.46)

Portal vein base excess

(mmol/L)

Control

10.8 (9.5 to 12.5)

10.2 (8.1 to 11.2)b

6.5 (3.0 to 8.2)b

4.8 (0.1 to 6.2)b

 

AVP

9.8 (7.8 to 12.4)

9.2 (7.3 to 10.4)

9.5 (6.0 to 10.6)

8.9 (3.0 to 11.0)a

Hepatic vein base excess (mmol/L)

Control

12.6 (10.5 to 14.2)

11.1 (7.9 to 12.2)b

7.6 (5.1 to 8.9)b

5.8 (0.5 to 7.4)b

 

AVP

11.6 (10.1 to 14.8)

10.5 (8.5 to 12.2)b

9.8 (4.5 to 11.1)b

9.0 (3.8 to 11.8)b

ICG plasma

Control

20 (19 to 23)

17 (13 to 31)

14 (10 to 34)

13 (8 to 22)b

disappearance rate (%/min)

AVP

15 (11 to 19)

14 (10 to 18)

13 (8 to 15)

12 (12 to 15)

Urine output

(mL/kg/h)

Control

5.4 (4.1 to 7.2)

3.2 (2.3 to 4.8)b

 

AVP

6.7 (5.9 to 8.0)

5.6 (4.6 to 8.6)a

Creatinine clearance

(mL/min)

Control

80 (67 to 88)

64 (35 to 85)c

 

AVP

79 (60 to 98)

61 (44 to 73)c

Fractional Na+ excretion (%)

Control

AVP

5.6 (4.8 to 7.7)

3.0 (2.5 to 5.1)

  

8.3 (6.4 to 10.0)a

9.5 (7.2 to 10.7)a

  1. Data on urine flow, creatinine clearance, and fractional Na+ excretion refer to the first and second half of the experiment, respectively. All data are median (quartiles). a P < 0.05 between norepinephrine- and AVP-treated animals; b P < 0.05 within groups versus before peritonitis.
  2. AVP = arginine vasopressin; ICG = indocyanine-green dye.